Swedish Pharma Stock News

Gruvaktiebolaget Viscaria (OM:VISC) has just closed FY 2025 with fourth quarter revenue of 77.8 million SEK and a net income loss of 41.4 million SEK, which translated to EPS of 0.172268 SEK. Over recent periods, the company has seen quarterly revenue move between 57.8 million SEK and 84.5 million SEK, while EPS has ranged from 0.165593 SEK to 0.260878 SEK alongside widening losses on a trailing twelve month basis. This sets up a results story focused on how much pressure margins can absorb...

Wihlborgs Fastigheter (OM:WIHL) has wrapped up FY 2025 with Q4 revenue of SEK 1,184 million and basic EPS of SEK 2.76. Trailing 12 month figures sit at SEK 4,354 million in revenue and SEK 7.22 in basic EPS, supported by a net profit margin of 51% that is higher than the prior year's 40.7%. Over the past few quarters, revenue has moved from SEK 1,065 million in Q4 2024 to SEK 1,184 million in Q4 2025. Quarterly EPS has ranged from SEK 1.40 in Q1 2025 to SEK 2.80 in Q4 2024, giving investors a...

Storskogen Group (OM:STOR B) has wrapped up FY 2025 with fourth quarter revenue of about SEK 8.7b and basic EPS of SEK 0.38, while the trailing twelve months show total revenue of roughly SEK 33.1b and basic EPS of SEK 0.63 as the business remained profitable over the period. The company has seen quarterly revenue range between roughly SEK 7.9b and SEK 8.7b across 2025, with basic EPS moving from SEK 0.11 in Q1 to SEK 0.38 in Q4, against a backdrop where five year earnings previously declined...

Thule Group FY 2025 Earnings Snapshot Thule Group (OM:THULE) has wrapped up FY 2025 with Q4 revenue of SEK 1.8b and basic EPS of SEK 0.19, alongside trailing twelve month revenue of SEK 10.4b and EPS of SEK 10.33. The company reported quarterly revenue of SEK 2.7b in Q1 2025, SEK 3.4b in Q2, SEK 2.5b in Q3 and SEK 1.8b in Q4, while EPS over the same periods came in at SEK 2.47, SEK 4.75, SEK 2.91 and SEK 0.19. This provides context for investors assessing how margins have developed over the...

Asker Healthcare Group (OM:ASKER) FY 2025 Results Snapshot Asker Healthcare Group (OM:ASKER) has wrapped up FY 2025 with fourth quarter revenue of SEK4.7 billion and basic EPS of 0.34 SEK, setting the tone for how investors assess the full year. Over recent periods, the company has seen quarterly revenue move from SEK4.3 billion and EPS of 0.24 SEK in Q4 2024 to SEK4.7 billion and EPS of 0.34 SEK in Q4 2025. Trailing twelve month EPS came in at 1.25 SEK on revenue of SEK16.8 billion, giving...

Alimak Group (OM:ALIG) has wrapped up FY 2025 with fourth quarter revenue of SEK 1,692 million and basic EPS of SEK 0.98, setting the tone for how investors will parse the full year. The company has seen quarterly revenue move between SEK 1,658 million and SEK 1,791 million through 2025, with EPS ranging from SEK 0.98 to SEK 1.74. Trailing twelve month EPS for the period ended Q4 2025 is SEK 5.71. With trailing net margin at 9.9% and recent earnings growth in the backdrop, this latest print...

NP3 Fastigheter (OM:NP3) just released its fourth quarter and full year 2025 results, with higher reported sales, net income and earnings per share. This puts the latest earnings call in clear focus for investors. See our latest analysis for NP3 Fastigheter. Following the earnings release and call on 6 February 2026, NP3 Fastigheter’s share price has moved to SEK272.0, with a 1-day share price return of 1.87% and a 7-day share price return of 4.62%. Its 1-year total shareholder return of...

EQT (OM:EQT) is back in focus after its EQT Life Sciences arm co led a $39 million Series A round for Aerska, a biotech developing RNA medicines for neurological diseases using brain shuttle technology. See our latest analysis for EQT. EQT’s recent Aerska funding and infrastructure deal interest come after a tougher few months for the share price, with a 30 day share price return of 15.81% decline and a 1 year total shareholder return of 16.12% decline, while longer term total shareholder...

ITAB Shop Concept AB (publ)'s ( STO:ITAB ) price-to-earnings (or "P/E") ratio of 17.9x might make it look like a buy...

In February 2026, global markets are experiencing a dynamic shift as small-cap and value-oriented stocks make gains amid a cooling U.S. labor market and volatility in large-cap technology shares. With the S&P MidCap 400 and Russell 2000 indices showing solid performance, investors are increasingly interested in small-cap opportunities that demonstrate resilience and potential for growth. In this context, identifying a good stock often involves looking at companies with strong fundamentals...

Key Insights Institutions' substantial holdings in Intea Fastigheter implies that they have significant influence over...

Key Insights Significant control over Hanza by private companies implies that the general public has more power to...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Medicover AB (publ)'s ( STO:MCOV B ) price-to-earnings (or "P/E") ratio of 46.4x might make it look like a strong sell...

It's been a pretty great week for Knowit AB (publ) ( STO:KNOW ) shareholders, with its shares surging 13% to kr128 in...

SkiStar AB (publ) ( STO:SKIS B ), is not the largest company out there, but it saw a decent share price growth of 12...

As you might know, Balco Group AB ( STO:BALCO ) recently reported its annual numbers. Revenues came in at kr1.3b, in...

Nelly Group AB (publ) ( STO:NELLY ) shareholders won't be pleased to see that the share price has had a very rough...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

It's been a pretty great week for CTEK AB (publ) ( STO:CTEK ) shareholders, with its shares surging 12% to kr14.00 in...

Attendo (OM:ATT) is back in focus after reporting fourth quarter and full year 2025 results, with net income and earnings per share higher on broadly stable revenue, alongside an announced annual dividend of SEK 1.80 per share. See our latest analysis for Attendo. Alongside the stronger earnings and new dividend, Attendo’s share price has climbed, with a 30 day share price return of 20.10% and a year to date share price return of 26.73%. The 1 year total shareholder return of 64.75% and very...

Nyfosa (OM:NYF) closed out FY 2025 with Q4 revenue of SEK 905 million and EPS of SEK 0.89. On a trailing twelve month basis, EPS came in at SEK 2.45 and revenue at SEK 3.59 billion, setting the backdrop for a year where reported earnings swung sharply. Over recent quarters the company has seen quarterly revenue move in a tight band between SEK 884 million and SEK 925 million, with EPS ranging from a loss of SEK 0.33 in Q2 2025 to SEK 1.38 in Q3 2025. The trailing net profit margin currently...